Moomoo AI 已提取核心信息
Patrick J Heron, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a purchase of 21,052 shares of common stock on March 4, 2024. The transaction was conducted in the open market at a price of $9.50 per share. Following this transaction, the total number of shares beneficially owned by Heron through direct and indirect holdings is 23,688. The indirect shares are held by Frazier Life Sciences VIII, L.P. This acquisition reflects a significant investment in the company, with the total value of the purchased shares amounting to approximately $199,994.
Patrick J Heron, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a purchase of 21,052 shares of common stock on March 4, 2024. The transaction was conducted in the open market at a price of $9.50 per share. Following this transaction, the total number of shares beneficially owned by Heron through direct and indirect holdings is 23,688. The indirect shares are held by Frazier Life Sciences VIII, L.P. This acquisition reflects a significant investment in the company, with the total value of the purchased shares amounting to approximately $199,994.
与Arcutis Biotherapeutics, Inc. [ARQT] 相关的帕特里克·赫伦于2024年3月4日完成了对21,052股普通股的购买。该交易在公开市场上进行，价格为每股9.50美元。此次交易后，Heron通过直接和间接持股实益拥有的股份总数为23,688股。间接股份由弗雷泽生命科学VIII, L.P持有。此次收购反映了对该公司的重大投资，购买的股份总价值约为199,994美元。
与Arcutis Biotherapeutics, Inc. [ARQT] 相关的帕特里克·赫伦于2024年3月4日完成了对21,052股普通股的购买。该交易在公开市场上进行，价格为每股9.50美元。此次交易后，Heron通过直接和间接持股实益拥有的股份总数为23,688股。间接股份由弗雷泽生命科学VIII, L.P持有。此次收购反映了对该公司的重大投资，购买的股份总价值约为199,994美元。
有用
没用